DiaMedica shareholders elect all 7 director nominees, ratify auditor, approve say-on-pay

DiaMedica Therapeutics Inc.

Michael Giuffre, Rick Kuntz, Tanya Lewis, Daniel O'Connor, James Parsons, Rick Pauls, Charles Semba elected with 96.3% or more of votes cast.
Appointment of Baker Tilly US, LLP as auditor for FY2025 approved with 95.5% of votes cast.
Advisory vote on executive compensation passed with 94.1% of votes cast (excluding broker non-votes).
Quorum reached with 45.1% of outstanding shares (19.34M of 42.86M) present at May 15, 2025 AGM.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.